SWIFTWATER, Pa. and LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant.
Sanofi pasteur has shipped to the U.S. National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS), 15,000 investigational doses of a vaccine to protect against the H5N1 influenza strain. Prepared with different levels of antigen, the investigational doses will be used in the NIH's clinical studies to determine the optimal formulation of the vaccine. The investigational doses include the use of the adjuvant, aluminum hydroxide (alum), that could increase the vaccine's effectiveness and enable the use of less antigen in each dose. The end result could be a greater number of doses available to immunize more people.
In addition, the company has completed production of additional bulk-concentrate of the H5N1 vaccine antigen for the U.S. government stockpile. Once the optimal dosage is established, the bulk-concentrate antigen will be ready for final formulation and filling into doses.
The additional H5N1 bulk-concentrate vaccine represents a broadening of a contract the company signed in September 2005 with the U.S. Department of Health and Human Services (HHS) to produce a stockpile of the H5N1 vaccine valued at $100 million. The additional bulk concentrate vaccine just produced is valued at $50 million and will support U.S. Department of Defense requirements.
The bulk-concentrate and the investigational doses were produced at sanofi pasteur's U.S. site in Swiftwater, Pa.
Source: sanofi-pasteur
  Â
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.